BridgeBio Oncology Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBOT and other ETFs, options, and stocks.About BBOT
Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies.
BBOT Key Statistics
Stock Snapshot
As of today, BridgeBio Oncology Therapeutics(BBOT) shares are valued at $8.21. The company's market cap stands at 648.87M, with a P/E ratio of -0.02.
On 2026-07-05, BridgeBio Oncology Therapeutics(BBOT) stock moved within a range of $7.72 to $8.29. With shares now at $8.21, the stock is trading +6.3% above its intraday low and -1.0% below the session's peak.
Trading volume for BridgeBio Oncology Therapeutics(BBOT) stock has reached 401.58K, versus its average volume of 710.12K.
Over the past 52 weeks, BridgeBio Oncology Therapeutics(BBOT) stock has traded between a high of $14.87 and a low of $7.00.
Over the past 52 weeks, BridgeBio Oncology Therapeutics(BBOT) stock has traded between a high of $14.87 and a low of $7.00.
Analyst ratings
100%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.